EMD 55900

Drug Profile

EMD 55900

Alternative Names: Anti-epidermal growth factor receptor monoclonal antibody 425; MAb 425; Monoclonal antibody 425

Latest Information Update: 08 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Merck KGaA
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Epidermal growth factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Glioma

Most Recent Events

  • 01 Aug 1997 Phase-I clinical trials for Glioma in Sweden (Intratumoural)
  • 01 Aug 1997 A study has been added to the adverse events section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top